Abstract 174P
Background
Application of computer and artificial intelligence (AI) has made revolutionary progress in medical fields. Computer-assisted diagnosis (CAD) on pathology is successful in diagnosis, classification, staging and predicting prognosis of cancer.
Methods
In this work, we used the technique of convolutional neural networks (CNN) for training of morphological images of gastric cancer, which is a promising application of artificial intelligence technique for medical image analysis, especially for cancer pathology.
Results
We introduced successful works of AI-aided gastric cancer analysis for over 300 cases. AI-assisted pathology technique could help the pathologist in detecting and locating the abnormal area in images and to diagnose and classify benign or malignant tissues. Therefore, AI exactly improves the diagnostic status of gastric cancer, such as in interpretation of medical images and classification between benign and cancerous tissues. The complete workflow of AI diagnosis for gastric cancer is under construction. AI is more useful in releasing pathologists from repeated work, and improving efficiency.
Conclusions
In conclusions, there are still notable technical obstacles before this approach can be used to improve conventional clinical practice. Higher performance needs corrected marking images by experienced pathologist and require ‘training’ algorithms on tremendous data. We stressed the importance of proper algorithms for improving confidence of analytic results that is close to human experts. Additionally, we indicated the gaps in current research and principal resolutions for advancing the field.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors without further recourse to the authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
41P - Clinical verification on the relationship between serum lipid metabolism and the immune microenvironment in breast cancer patients
Presenter: Wataru Goto
Session: Poster display session
Resources:
Abstract
42P - Genome wide copy number analysis of circulating tumour cells in breast cancer liver metastasis
Presenter: Saber Imani
Session: Poster display session
Resources:
Abstract
43P - A hotspot variants p.H1047R and p.H1047L in p110α/ΔNp63α complex affects structure, function and contributes to susceptibility metastatic breast cancer
Presenter: Zou Linglin
Session: Poster display session
Resources:
Abstract
44P - Correlation of circulating tumour cells with PET-CT in metastatic breast cancer
Presenter: Venkata Pradeep Babu Koyyala
Session: Poster display session
Resources:
Abstract
45P - The challenge of evaluating new targeted therapies: Opportunities in stratifying the therapeutic response per tumour location
Presenter: Hubert Beaumont
Session: Poster display session
Resources:
Abstract
46P - Plasma soluble CD36 of breast cancer based on pathological and clinical characteristics
Presenter: Aditia Romadhoni
Session: Poster display session
Resources:
Abstract
47P - Investigation of the use of a novel S-1 administration method for treating metastatic and recurrent breast cancer
Presenter: MAYUKO MIKI
Session: Poster display session
Resources:
Abstract
48P - Development of MDA-MB-231-3D-Spheroid as a reliable model for studying Nav1.5 and nNav1.5-mediated breast cancer metastasis
Presenter: Ahmad Murtadha
Session: Poster display session
Resources:
Abstract
49P - Biochemical study on modifying role of variants of leptin gene and its receptor on serum leptin levels in breast cancer
Presenter: Alshimaa Alhanafy
Session: Poster display session
Resources:
Abstract
50P - Prognostic factors of recurrence or distant metastasis in elderly breast cancer patients
Presenter: Seungju Lee
Session: Poster display session
Resources:
Abstract